| Biomarkers for combination therapies |
2023-3-06 |
2023-11-02 |
|
| Biomarkers for combination therapies |
2023-3-06 |
2023-9-14 |
|
| Predictive biomarkers for onvansertib treatment |
2022-12-09 |
2023-6-15 |
|
| Cancer treatment using lsd1 inhibitors and plk1 inhibitors |
2022-11-16 |
2023-5-25 |
|
| Cancer treatment using fgfr inhibitors and plk1 inhibitors |
2022-10-14 |
2023-4-20 |
|
| Cancer treatment using parp inhibitors and plk1 inhibitors |
2022-4-08 |
2022-10-13 |
|
| Selection and treatment of cancer with combination therapies |
2021-8-27 |
2022-3-17 |
|
| Methods of monitoring kras mutations |
2021-5-06 |
2023-6-08 |
|
| Treatment of leukemias and lymphomas with combinations of bcl-2 inhibitors and … |
2021-1-29 |
2021-8-05 |
|
| Circulating tumor dna as a biomarker for leukemia treatment |
2021-1-13 |
2021-7-22 |
|
| Inhibitors of PLK1 and PSA levels in prostate cancer |
2020-3-25 |
2022-1-07 |
|
| Onvansertib for inhibiting non-adrenergic contraction of smooth muscle and … |
2020-2-25 |
2022-1-05 |
|
| Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses … |
2019-10-10 |
2020-1-30 |
|
| PLK1 target phosphorylation status and treatment of cancer with PLK1 inhibitors |
2019-8-24 |
2021-6-29 |
|
| Concentrating nucleic acids in urine |
2016-10-20 |
2017-4-06 |
|
| Synthesis and enrichment of nucleic acid sequences |
2016-9-03 |
2017-1-12 |
|
| Method for detection of human papillomavirus |
2016-7-25 |
2017-1-19 |
|
| Early assessment of mechanism of action and efficacy of anti-cancer therapies … |
2016-3-04 |
2018-3-29 |
|
| Detecting mutations in disease over time |
2016-1-02 |
2016-4-28 |
|
| Detection of nucleic acids in urine |
2015-8-20 |
2016-1-07 |
|
| Amplification and sequencing of transrenal nucleic acids |
2015-8-06 |
2015-11-19 |
|
| Monitoring treatment of histiocytosis with vemurafenib and dabrafenib |
2015-5-30 |
2015-12-03 |
|
| Compositions, methods and kits for isolating nucleic acids from body fluids … |
2015-4-30 |
2018-3-06 |
2018-3-06 |
| Synthesis and enrichment of nucleic acid sequences |
2014-10-20 |
2015-5-21 |
|
| Synthesis and enrichment of nucleic acid sequences |
2014-10-20 |
2016-11-09 |
|
| Detecting mutations in disease over time |
2014-10-19 |
2016-6-22 |
|
| Detecting and monitoring mutations in histiocytosis |
2014-10-18 |
2015-5-14 |
|
| Detecting and monitoring mutations in histiocytosis |
2014-10-18 |
2017-5-17 |
|
| Hpv detection in urine |
2014-8-28 |
2016-7-13 |
|
| Methods of Using miRNA for Detection of In Vivo Cell Death |
2014-8-11 |
2014-8-28 |
|
| Composition and method for detecting viral specific nucleic acid in urine |
2013-3-04 |
2013-7-25 |
|
| Method for diagnosis and monitoring of viral infection by analysis of viral … |
2013-2-26 |
2013-7-11 |
|
| Methods of detecting braf mutations in cancer |
2012-10-23 |
2013-5-02 |
|
| Mutations in SF3B1 and chronic lymphocytic leukemia |
2012-9-29 |
2017-2-17 |
2017-2-17 |
| Method for monitoring minimal residual hairy cell leukemia |
2012-5-10 |
2015-12-29 |
2015-12-29 |
| Conjugate probes and optical detection of analytes |
2012-4-19 |
2012-8-09 |
|
| Compositions and methods for detecting viral specific nucleic acids in urine |
2006-2-16 |
2006-8-24 |
|
| Compositions and methods for detecting specific nucleic acids of urine … |
2006-2-14 |
2015-4-16 |
2015-4-16 |
| Compositions and methods for detecting pathogen specific nucleic acids in urine |
2006-2-14 |
2008-2-13 |
|
| Methods for detecting pathogen specific nucleic acids in urine |
2006-2-10 |
2011-3-29 |
2011-3-29 |
| Biomarqueurs pour polythérapies |
2023-3-06 |
2023-11-02 |
|